Literature DB >> 29268377

Peroxisome proliferator-activated receptor-γ in induced sputum is correlated with MMP-9/TIMP-1 imbalance and formation of emphysema in COPD patients.

Xiao-Ming Zhou1,2, Gang Hou2,3, Dong-Xue Gu4, Qiu-Yue Wang2,3, Li Zhao1,2.   

Abstract

BACKGROUND: The development of chronic obstructive pulmonary disease (COPD) is modulated by the symmetry of matrix metalloproteinases (MMPs) and the counter-acting tissue inhibitors of metalloproteinases (TIMPs). We investigated the interaction between peroxisome proliferator-activated receptor gamma (PPARγ) expression and the imbalance of MMP-9/TIMP-1 in the induced sputum of stable COPD patients.
METHODS: Sixty-six stable COPD patients were enrolled and the induced sputum samples were gathered. The correlation between PPARγ and other index, including MMP-9, TIMP-1, pulmonary function and the index of emphysema-the percentage of low attenuation area (LAA%), was analyzed.
RESULTS: PPARγ and TIMP-1 concentrations were decreased and the concentration of MMP-9 and the ratio of MMP9/TIMP1 were enhanced in the induced sputum of COPD patients, compared to the healthy controls. Among COPD patients, those with worse lung function or patients with emphysema exhibited increased MMP-9 expression with decreased TIMP-1 and PPARγ expression. Besides, the concentration of PPARγ of the induced sputum was correlated with the forced expiratory volume in one second percentage (FEV1%) positively and the expression of TIMP-1; while it was negatively correlated with the residual volume (RV), RV/total lung capacity (TLC), LAA%, and MMP-9 expression.
CONCLUSIONS: Our findings reveal the protective role of PPARγ in the maintenance of the dynamic balance of MMP-9/TIMP-1 in COPD, thus providing evidence on which to base the potential COPD treatment.

Entities:  

Keywords:  Emphysema; PPAR gamma; chronic obstructive pulmonary disease; matrix metalloproteinase 9; tissue inhibitors of metalloproteinase 1

Year:  2017        PMID: 29268377      PMCID: PMC5723796          DOI: 10.21037/jtd.2017.09.10

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  42 in total

1.  Quality evaluation of samples obtained by spontaneous or induced sputum: comparison between two methods of processing and relationship with clinical and functional findings.

Authors:  M L Bartoli; E Bacci; S Carnevali; S Cianchetti; F L Dente; A Di Franco; D Giannini; M Taccola; B Vagaggini; P L Paggiaro
Journal:  J Asthma       Date:  2002-09       Impact factor: 2.515

2.  Matrix metalloproteinase expression and production by alveolar macrophages in emphysema.

Authors:  G A Finlay; L R O'Driscoll; K J Russell; E M D'Arcy; J B Masterson; M X FitzGerald; C M O'Connor
Journal:  Am J Respir Crit Care Med       Date:  1997-07       Impact factor: 21.405

Review 3.  Airway inflammation in chronic obstructive pulmonary disease.

Authors:  Nikolaos Angelis; Konstantinos Porpodis; Paul Zarogoulidis; Dionysios Spyratos; Ioannis Kioumis; Antonis Papaiwannou; Georgia Pitsiou; Kosmas Tsakiridis; Andreas Mpakas; Stamatis Arikas; Theodora Tsiouda; Nikolaos Katsikogiannis; Ioanna Kougioumtzi; Nikolaos Machairiotis; Michael Argyriou; George Kessisis; Konstantinos Zarogoulidis
Journal:  J Thorac Dis       Date:  2014-03       Impact factor: 2.895

Review 4.  The role of PPARs in inflammation and immunity.

Authors:  Robert B Clark
Journal:  J Leukoc Biol       Date:  2002-03       Impact factor: 4.962

5.  Expression of CREB-binding protein and peroxisome proliferator-activated receptor gamma during formoterol or formoterol and corticosteroid therapy of chronic obstructive pulmonary disease.

Authors:  A Holownia; R M Mroz; J Noparlik; E Chyczewska; J J Braszko
Journal:  J Physiol Pharmacol       Date:  2008-12       Impact factor: 3.011

6.  Inhibition of MMP-9 expression by PPARgamma activators in human bronchial epithelial cells.

Authors:  M Hetzel; D Walcher; M Grüb; H Bach; V Hombach; N Marx
Journal:  Thorax       Date:  2003-09       Impact factor: 9.139

7.  Differential expression and activation of a family of murine peroxisome proliferator-activated receptors.

Authors:  S A Kliewer; B M Forman; B Blumberg; E S Ong; U Borgmeyer; D J Mangelsdorf; K Umesono; R M Evans
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-19       Impact factor: 11.205

8.  SIRT1 redresses the imbalance of tissue inhibitor of matrix metalloproteinase-1 and matrix metalloproteinase-9 in the development of mouse emphysema and human COPD.

Authors:  Hongwei Yao; Jae-woong Hwang; Isaac K Sundar; Alan E Friedman; Michael W McBurney; Leonard Guarente; Wei Gu; Vuokko L Kinnula; Irfan Rahman
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-09-13       Impact factor: 5.464

9.  MMP-9, TIMP-1 and inflammatory cells in sputum from COPD patients during exacerbation.

Authors:  P F Mercer; J K Shute; A Bhowmik; G C Donaldson; J A Wedzicha; J A Warner
Journal:  Respir Res       Date:  2005-12-22

10.  Lung matrix metalloproteinase-9 correlates with cigarette smoking and obstruction of airflow.

Authors:  Min Jong Kang; Yeon-Mok Oh; Jae Cheol Lee; Dong Gyu Kim; Myung Jae Park; Myung Goo Lee; In Gyu Hyun; Sung Koo Han; Young-Soo Shim; Ki-Suck Jung
Journal:  J Korean Med Sci       Date:  2003-12       Impact factor: 2.153

View more
  2 in total

1.  Effects of cannabis oil extract on immune response gene expression in human small airway epithelial cells (HSAEpC): implications for chronic obstructive pulmonary disease (COPD).

Authors:  Stephen W Mamber; Volkan Gurel; Jeremy Lins; Fred Ferri; Sarah Beseme; John McMichael
Journal:  J Cannabis Res       Date:  2020-01-31

2.  Zeylenone represses the progress of human prostate cancer by downregulating the Wnt/β‑catenin pathway.

Authors:  Shaohua Zeng; Baoyi Zhu; Jun Zeng; Wenqi Wu; Chonghe Jiang
Journal:  Mol Med Rep       Date:  2018-10-17       Impact factor: 2.952

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.